OPTIFAST - The Proven Medically Supervised Weight Loss Program

NEW Clinical study released at Obesity week!

See the Press Release
Learn More about the Weight LossResults from this New Clinical Study

The science-based program that delivers weight loss for health gains

  • Approximately 30-lbs weight loss with the 26-week OPTIFAST® program.1
  • Weight loss with the OPTIFAST® program can help lower cholesterol and triglyceride levels, blood glucose levels, blood pressure, and waist size.1-4

OPTIFAST® Success Stories

Lost

40 lbs*

“The OPTIFAST program helped me to reset the way I thought about food to find self-control when I did not have it before. If I could say anything to my old self, it would be just do it. It's going to be the best thing you ever did for your health.”

* OPTIFAST® patients who actively participate in a 26-week program typically lose approximately 30 pounds with weight loss-related improvements in blood glucose, blood pressure, and cholesterol levels.1-4
**Maintaining a healthy weight is associated with reduced risk of diabetes, heart disease, sleep apnea, and increased life expectancy.  These benefits are not limited or attributed to weight loss with the OPTIFAST® Program, specifically. However, no patient’s case is typical. 

References:

  • Ard JD, Lewis KH, Rothberg A, et al. Effectiveness of a total meal replacement program (OPTIFAST® program) on weight loss: results from the OPTIWIN study. Obesity. 2018; doi: 10.1002/oby.22303.
  • Wadden TA, Foster GD, Letizia KA, Stunkard AJ. A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity. Arch Intern Med. 1992;152(5):961-6.  
  • Drawert S, Bedford K, Largent D. Change in glucose, blood pressure, and cholesterol with weight loss in medically obese patients. Obese Res. 1996;4(S1)67S.
  • Ard J, Schroeder M, Kivilaid K, Swanson J, Hayes E, Olesen M. Effects of the practical application of a medically monitored, comprehensive weight management program on risk factors associated with the metabolic syndrome. J Obes Wt Loss Ther. 2014;S4.

The OPTIFAST® Team is working with professional associations in the research and treatment of Obesity. OPTIFAST® is an active member of the American Society of Metabolic and Bariatric Surgery (ASMBS) and Obesity Action Coalition (OAC) and participates in the Corporate Advisory Council of The Obesity Society (TOS) and The Obesity Medicine Association (OMA). References to these associations are not intended as an endorsement of the OPTIFAST® program.

  • oma-logo
  • NewASMBSLogo
  • oac-logo
  • os-logo